|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Immune system
|
 |
|
Title:
|
 |
The hapten complexed germline precursor to sulfide oxidase catalytic antibody 28b4
|
|
Structure:
|
 |
Antibody germline precursor to 28b4. Chain: l, a. Fragment: light chain (chains l and a). Engineered: yes. Mutation: yes. Antibody germline precursor to 28b4. Chain: h, b. Fragment: heavy chain (chains h and b). Engineered: yes.
|
|
Source:
|
 |
Mus musculus. House mouse. Organism_taxid: 10090. Expressed in: escherichia coli. Expression_system_taxid: 562. Homo sapiens. Human. Organism_taxid: 9606. Expression_system_taxid: 562
|
|
Biol. unit:
|
 |
Dimer (from
)
|
|
Resolution:
|
 |
|
2.80Å
|
R-factor:
|
0.216
|
R-free:
|
0.271
|
|
|
Authors:
|
 |
J.Yin,E.C.Mundorff,P.L.Yang,K.U.Wendt,D.Hanway,R.C.Stevens, P.G.Schultz
|
Key ref:
|
 |
J.Yin
et al.
(2001).
A comparative analysis of the immunological evolution of antibody 28B4.
Biochemistry,
40,
10764-10773.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
11-Aug-00
|
Release date:
|
14-Nov-01
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Biochemistry
40:10764-10773
(2001)
|
|
PubMed id:
|
|
|
|
|
| |
|
A comparative analysis of the immunological evolution of antibody 28B4.
|
|
J.Yin,
E.C.Mundorff,
P.L.Yang,
K.U.Wendt,
D.Hanway,
R.C.Stevens,
P.G.Schultz.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
In an effort to gain greater insight into the evolution of the redox active,
catalytic antibody 28B4, the germline genes used by the mouse to generate this
antibody were cloned and expressed, and the X-ray crystal structures of the
unliganded and hapten-bound germline Fab of antibody 28B4 were determined.
Comparison with the previously determined structures of the unliganded and
hapten-bound affinity-matured Fab [Hsieh-Wilson, L. C., Schultz, P. G., and
Stevens, R. C. (1996) Proc. Natl. Acad. Sci. U.S.A. 93, 5363] shows that the
germline antibody binds the p-nitrophenyl ring of hapten 3 in an orientation
significantly different from that seen in the affinity-matured antibody, whereas
the phosphonate moiety is bound in a similar mode by both antibodies. The
affinity-matured antibody 28B4 has more electrostatic and hydrophobic
interactions with hapten 3 than the germline antibody and binds the hapten in a
lock-and-key fashion. In contrast, significant conformational changes occur in
the loops of CDR H3 and CDR L1 upon hapten binding to the germline antibody,
consistent with the notion of structural plasticity in the germline
antibody-combining site [Wedemayer, G. J., Patten, P. A., Wang, L. H., Schultz,
P. G., and Stevens, R. C. (1997) Science 276, 1665]. The structural differences
are reflected in the differential binding affinities of the germline Fab (K(d) =
25 microM) and 28B4 Fab (K(d) = 37 nM) to hapten 3. Nine replacement mutations
were found to accumulate in the affinity-matured antibody 28B4 compared to its
germline precursor. The effects of each mutation on the binding affinity of the
antibody to hapten 3 were characterized in detail in the contexts of both the
germline and the affinity-matured antibodies. One of the mutations, Asp95(H)Trp,
leads to a change in the orientation of the bound hapten, and its presence is a
prerequisite for other somatic mutations to enhance the binding affinity of the
germline antibody for hapten 3. Thus, the germline antibody of 28B4 acquired
functionally important mutations in a stepwise manner, which fits into a
multicycle mutation, affinity selection, and clonal expansion model for germline
antibody evolution. Two other antibodies, 20-1 and NZA6, with very different
antigen specificities were found to be highly homologous to the germline
antibody of 28B4, consistent with the notion that certain germline
variable-region gene combinations can give rise to polyspecific hapten binding
sites [Romesberg, F. E., Spiller, B., Schultz, P. G., and Stevens, R. C. (1998)
Science 279, 1929]. The ultimate specificity of the polyspecific germline
antibody appears to be defined by CDR H3 variability and subsequent somatic
mutation. Insights into the evolution of antibody-combining sites provided by
this and other structural studies are discussed.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
S.E.Wong,
B.D.Sellers,
and
M.P.Jacobson
(2011).
Effects of somatic mutations on CDR loop flexibility during affinity maturation.
|
| |
Proteins,
79,
821-829.
|
 |
|
|
|
|
 |
S.P.Persaud,
D.L.Donermeyer,
K.S.Weber,
D.M.Kranz,
and
P.M.Allen
(2010).
High-affinity T cell receptor differentiates cognate peptide-MHC and altered peptide ligands with distinct kinetics and thermodynamics.
|
| |
Mol Immunol,
47,
1793-1801.
|
 |
|
|
|
|
 |
J.Morfill,
K.Blank,
C.Zahnd,
B.Luginbühl,
F.Kühner,
K.E.Gottschalk,
A.Plückthun,
and
H.E.Gaub
(2007).
Affinity-matured recombinant antibody fragments analyzed by single-molecule force spectroscopy.
|
| |
Biophys J,
93,
3583-3590.
|
 |
|
|
|
|
 |
D.K.Sethi,
A.Agarwal,
V.Manivel,
K.V.Rao,
and
D.M.Salunke
(2006).
Differential epitope positioning within the germline antibody paratope enhances promiscuity in the primary immune response.
|
| |
Immunity,
24,
429-438.
|
 |
|
|
|
|
 |
G.Thom,
A.C.Cockroft,
A.G.Buchanan,
C.J.Candotti,
E.S.Cohen,
D.Lowne,
P.Monk,
C.P.Shorrock-Hart,
L.Jermutus,
and
R.R.Minter
(2006).
Probing a protein-protein interaction by in vitro evolution.
|
| |
Proc Natl Acad Sci U S A,
103,
7619-7624.
|
 |
|
|
|
|
 |
J.Zimmermann,
E.L.Oakman,
I.F.Thorpe,
X.Shi,
P.Abbyad,
C.L.Brooks,
S.G.Boxer,
and
F.E.Romesberg
(2006).
Antibody evolution constrains conformational heterogeneity by tailoring protein dynamics.
|
| |
Proc Natl Acad Sci U S A,
103,
13722-13727.
|
 |
|
|
|
|
 |
K.S.Midelfort,
and
K.D.Wittrup
(2006).
Context-dependent mutations predominate in an engineered high-affinity single chain antibody fragment.
|
| |
Protein Sci,
15,
324-334.
|
 |
|
|
|
|
 |
N.S.Longo,
and
P.E.Lipsky
(2006).
Why do B cells mutate their immunoglobulin receptors?
|
| |
Trends Immunol,
27,
374-380.
|
 |
|
|
|
|
 |
K.S.Weber,
D.L.Donermeyer,
P.M.Allen,
and
D.M.Kranz
(2005).
Class II-restricted T cell receptor engineered in vitro for higher affinity retains peptide specificity and function.
|
| |
Proc Natl Acad Sci U S A,
102,
19033-19038.
|
 |
|
|
|
|
 |
L.Zheng,
R.Manetsch,
W.D.Woggon,
U.Baumann,
and
J.L.Reymond
(2005).
Mechanistic study of proton transfer and hysteresis in catalytic antibody 16E7 by site-directed mutagenesis and homology modeling.
|
| |
Bioorg Med Chem,
13,
1021-1029.
|
 |
|
|
|
|
 |
L.Zheng,
U.Baumann,
and
J.L.Reymond
(2004).
Molecular mechanism of enantioselective proton transfer to carbon in catalytic antibody 14D9.
|
| |
Proc Natl Acad Sci U S A,
101,
3387-3392.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
R.Jimenez,
G.Salazar,
J.Yin,
T.Joo,
and
F.E.Romesberg
(2004).
Protein dynamics and the immunological evolution of molecular recognition.
|
| |
Proc Natl Acad Sci U S A,
101,
3803-3808.
|
 |
|
|
|
|
 |
J.Yin,
S.E.Andryski,
A.E.Beuscher,
R.C.Stevens,
and
P.G.Schultz
(2003).
Structural evidence for substrate strain in antibody catalysis.
|
| |
Proc Natl Acad Sci U S A,
100,
856-861.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
R.L.Rich,
and
D.G.Myszka
(2002).
Survey of the year 2001 commercial optical biosensor literature.
|
| |
J Mol Recognit,
15,
352-376.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
');
}
}
 |